FDA "self-punching"? Can chloroquine and hydroxychloroquine treat COVID-19?

The antimalarial drugs chloroquine and hydroxychloroquine have been on the big stage since the "new medicines for new coronary pneumonia" were introducedSweden, France and other countries to discontinue (hydroxy) chloroquine treatment COVID-19 patientsThe FDA's former head of emergency use of malaria drugs (EUA) has condemned the practice, which he says undermines the agency's scientific authorityThe U.SCenters for Disease Control and Prevention (CDC) published a drug guide entitled "Clinicians' Information on Treatment Options for New Coronary Pneumonia Patients," which includes key dose information on the drug chloroquine and hydroxychloroquine treatment COVID-19, but the CDC removed the guideline from its official website just three days after it was publishedRick Bright, director of the U.SBiomedical Research and Development Agency (BARDA), has come under political pressure to leave his job after resisting funding for the use of UNproven antimalarial drugs for COVID-19in clinical studies, earlier this month, researchers in Brazil stopped part of the hydroxychloroquine study because some patients had heart rhythm problems after being tested for two higher doses of the drug, and the U.SVeterans Health Administration Medical Center found that the experimental group "receiving hydroxychloroquine treatment" for new coronary pneumonia had a higher mortality rate! The researchers also tested the effects of azithromycin, which did not reduce the risk of using a ventilator, whether or not it was associated with azithromycinrecent days, chloroquine and hydroxychloroquine have returned to the status of the situationAccording to internal emails published by Vanity Fair, a US magazine, the Trump administration is pressuring federal health officials to provide the malaria drug chloroquine to the public for the treatment of COVID-19 without medical supervisionThe strategy has also caused panic and opposition from scientists and doctors at some federal health agencies, who say they refuse to suspend drug regulationOn Friday, the FDA released a new drug safety report on known side effects of oxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problemsThis is also the FDA's first release of the relevant content for the treatment of COVID-19 patients with hydroxychloroquine and chloroquine since the emergency authorization of hydroxychloroquine and chloroquineFDA said that according to case reports in the FDA's adverse event reporting system database, COVID-19 patients had serious heart rhythm problems when treated with the drug or similar compound chloroquine, commonly used in combination with the antibiotic azithromycin, a drug used decades ago to treat arthritis, lupus and malaria, and that their side effects on the heart were knownAlthough the FDA had given emergency authorization to treat COVID-19 for oxychloroquine and chloroquine as early as a month ago, it was approved by the FDA earlier this week for Phase III clinical trials for the treatment of COVID-19, and in this report, the FDA noted that the FDA has not yet approved hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19report, the FDA warned people not to use hydroxychloroquine and chloroquine treatment without permission, and the results of clinical trials have not yet been announced, and emergency authorization for hydroxychloroquine and chloroquine applies only to hospitalized patients The FDA also encourages health care professionals to carefully screen and monitor each patient to help mitigate these risks clinical trials of hydroxychloroquine are ongoing, and the Wall Street Journal reported that researchers plan to recruit 200,000 patients to participate in more than 100 studies on hydroxychloroquine days ago, the new crown "god drug" Remdesivir clinical research data out, the results are not satisfactory Trump's antimalarial drugs are on the rise During the COVID-19 pandemic, people from all walks of life in all countries wanted to find effective drugs at an early date, but for drugs, they still need to be tested to prove their safety and effectiveness, and political opinion cannot be the lever of left and right science reference source: 1 Coronavirus (COVID-19) Update: Appgens Importance of Close Patient Supervision for 'Off-Label' Use of Antimalarial Drugs to Take EmS Risks, Hearts Rhythm Ages 2.FDA warns s-out-of-the-coVID-19 drug hydroxyquine is n un suand (Hydroxy) chloroquine side effects? FDA's emergency authorization condemned! 5 Global shortage of raw materials is coming! Will China's breakout catch up with India?